IRVINE, Calif.--(BUSINESS WIRE)--Allergan, Inc., (NYSE:AGN) today announced that the company has received approval from the U.S. Food and Drug Administration (FDA) to market JUVÉDERM VOLUMA™ XC, the ...
At 3 months, findings showed 80.4% of patients treated with Juvéderm Voluma XC achieved at least a 1-point improvement in moderate to severe temple hollowing. The Food and Drug Administration (FDA) ...
The Food & Drug Administration has Ok'd Juvederm Voluma XC gel facial filler. It's the first one approved to help restore shape & volume to the cheeks. As a person ages, the cheek area loses volume.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback